Cargando…

Structural similarities between SARS-CoV2 3CL(pro) and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals

Considering the significant impact of the recent COVID-19 outbreak, development of broad-spectrum antivirals is a high priority goal to prevent future global pandemics. Antiviral development processes generally emphasize targeting a specific protein from a particular virus. However, some antiviral a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bafna, Khushboo, Cioffi, Christopher L., Krug, Robert M., Montelione, Gaetano T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638714/ https://www.ncbi.nlm.nih.gov/pubmed/36353143 http://dx.doi.org/10.3389/fchem.2022.948553

Ejemplares similares

Structural Similarity of SARS-CoV2 M(pro) and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics
por: Bafna, Khushboo, et al.
Publicado: (2020)

Protocol for production and purification of SARS-CoV-2 3CL(pro)
por: Mazzei, Luca, et al.
Publicado: (2023)

Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir
por: Bafna, Khushboo, et al.
Publicado: (2021)

Structure function characterization of SARS CoV2 proteases for COVID19 antiviral development
por: Greene-Cramer, Rebecca, et al.
Publicado: (2022)

Development of Broad‐Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CL(pro)
por: Bacha, Usman, et al.
Publicado: (2008)

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture
por: Bafna, Khushboo, et al.
Publicado: (2021)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Broad Spectrum Pro-Quorum-Sensing Molecules as Inhibitors of Virulence in Vibrios
por: Ng, Wai-Leung, et al.
Publicado: (2012)

Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Modified cyclodextrins as broad-spectrum antivirals
por: Jones, Samuel T., et al.
Publicado: (2020)

A broad-spectrum antiviral molecule, QL47, selectively inhibits eukaryotic translation
por: de Wispelaere, Mélissanne, et al.
Publicado: (2020)

Broad-Spectrum Allosteric Inhibition of Herpesvirus Proteases
por: Gable, Jonathan E., et al.
Publicado: (2014)

Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)

Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
por: Soto-Acosta, Ruben, et al.
Publicado: (2021)

Human coronavirus OC43 3CL protease and the potential of ML188 as a broad-spectrum lead compound: Homology modelling and molecular dynamic studies
por: Berry, Michael, et al.
Publicado: (2015)

Potential Broad Spectrum Inhibitors of the Coronavirus 3CL(pro): A Virtual Screening and Structure-Based Drug Design Study
por: Berry, Michael, et al.
Publicado: (2015)

The broad-spectrum antiviral functions of IFIT and IFITM proteins
por: Diamond, Michael S., et al.
Publicado: (2012)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Broad-Spectrum Antivirals Derived from Natural Products
por: Tian, Wen-Jun, et al.
Publicado: (2023)

Near-Infrared Dyes: Towards Broad-Spectrum Antivirals
por: Mariewskaya, Kseniya A., et al.
Publicado: (2022)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

Targeting papain-like protease for broad-spectrum coronavirus inhibition
por: Yuan, Shuofeng, et al.
Publicado: (2022)

DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CL(pro)) of SARS-CoV-2
por: Yadav, Pooja, et al.
Publicado: (2021)

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors
por: Mathew, Shilu, et al.
Publicado: (2018)

Broad-Spectrum Amino Acid Transporters ClAAP3 and ClAAP6 Expressed in Watermelon Fruits
por: Shi, Tianran, et al.
Publicado: (2019)

The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition
por: Goodier, John L., et al.
Publicado: (2015)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine
por: De Clercq, Erik, et al.
Publicado: (1990)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fr3cufo52t7kko0r32tgnr1m0e